According to the product performance of COVID-19 antigen detection reagent, the novel coronavirus antigen detection kit independently developed and produced by Novartis was awarded the medical device product registration certificate issued by the State Medical Device Product Supervision and Administration on March 1 1 2022, and the detection result was accurate. Fosun antigen generally refers to the detection of novel coronavirus antigen. At present, there is no authoritative research that clearly points out the accuracy of novel coronavirus antigen detection.
Novozan is a biotechnology company, which can carry out innovative research and development of information technology and product design and development around functional protein such as enzymes, antigens, antibodies and polymer organic materials. He has successively entered the fields of business management such as biological research, in vitro diagnosis and biomedicine. It is one of the few innovative small and medium-sized enterprises in China with independent and controllable upstream technology application and development capabilities and terminal product safety production and operation capabilities. 202 1 was listed on the science and technology innovation board.